| Code | CSB-RA943053A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
NLRP3 serves as a critical sensor component of the innate immune system, functioning as the core scaffolding protein of the NLRP3 inflammasome complex. This cytosolic pattern recognition receptor detects a diverse array of danger signals, from pathogen-associated molecular patterns to endogenous damage indicators, triggering caspase-1 activation and subsequent release of pro-inflammatory cytokines IL-1β and IL-18. Dysregulation of NLRP3 signaling has been implicated in numerous inflammatory conditions, including cryopyrin-associated periodic syndromes, gout, atherosclerosis, and neurodegenerative diseases, making it a compelling target for both basic immunology research and therapeutic development.
This recombinant monoclonal antibody, generated against a synthetic peptide derived from human NLRP3, offers the reproducibility and consistency that inflammasome research demands. As a sequence-defined recombinant clone, it eliminates the lot-to-lot variability that can complicate longitudinal studies or multi-site collaborations investigating inflammasome biology. The rabbit IgG format provides strong signal amplification while maintaining specificity for human NLRP3.
Validation studies demonstrate reliable performance in immunohistochemistry applications, with successful staining confirmed in paraffin-embedded human stomach tissue and human breast cancer specimens at 1:100 dilution using citrate buffer antigen retrieval. These results indicate utility for researchers examining NLRP3 expression patterns in both normal and pathological tissue contexts, including tumor microenvironment studies where inflammasome activity may influence disease progression.
The antibody is additionally validated for ELISA, providing flexibility for quantitative detection approaches. For investigators studying sterile inflammation, autoinflammatory disorders, or the emerging connections between inflammasome activation and cancer biology, this antibody delivers the technical consistency needed to generate reliable, publishable data.
There are currently no reviews for this product.